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This paper describes the investigation of the release mechanism of the cationic drug
coated with Surelease after curing compared with nonionic and anionic drug. The release
rate of cured propafenone hydrochloride pellets coated with Surelease was increased
significantly compared with uncured ones. The changes in release rate after seal-coating
proved the migration of drug into the polymer film. Based on a comparative study of
ammonia permeation tests and the impact of ammonia on drug with different properties, it
was shown that the change in release of the cationic drug after curing was related to the
combination of cationic drug and ammonia in Surelease. Also, the scanning electron
microscopy results showed that curing and dissolution can both prevent polymer film
coalescence. During coating, the evaporated ammonia combined with the cationic drug
and the polymer film coalesced. However, the combined ammonia could be decomposed
during curing and interrupt the coalescence of the polymer-coat, leading to increased
release. In an optimized process, the ammonia in the Surelease can be evaporated quickly
and the ionization of the drug will be reduced. All these factors can contribute to the
formation of the polymer film.
ª 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction residual toxic solvent and so most film coatings are water-Ethylcellulose (EC) is the most widely used water-insoluble
polymer for film-coating [1e3]. EC is tasteless, odorless, and
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Table 1 e Composition of pellet cores.
Ingredient Percentage (% w/w)
PPF MET NPS CBZ
Drug 50 20 50 20
MCC 40 80 50 80
Lactose 10 e e e
Binder
solution
1.5% w/v,
aqueous
solution
of PVP K30
Water 10% w/v,
aqueous
solution
of sodium
chloride
3% w/v, aqueous
solution of PVP K30
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and undergoing coagulation. But the aqueous suspension
system has the advantage of stickiness and a higher polymer
content which can shorten the processing time. In current
laboratory practice, Surelease and Aquacoat are two most
popular aqueous ethylcellulose dispersions.
Compared with Aquacoat, Surelease has many advan-
tages: plasticizers can be added during the preparation of
Surelease, and there is no need to add them before coating.
Since the polymer film is formed during coating, no curing is
needed after coating [4,5], which saves a lot of time during the
manufacturing process. Sadeghi investigated the release of
drug from pellets coated with Surelease containing hydrox-
ypropyl methylcellulose (HPMC) E15 [6,7]. Their results
showed that the release rate of drug decreased as the coating
load of Surelease increased. Mingxing Zhang [8] (2005) pre-
pared bilayer-pulsive pellets with Surelease as the control
layer and found no change in the release of theophylline from
pellets coated with Surelease after curing. In our study, the
release rate of both NPS (anionic drug) and CBZ (nonionic
drug) from pellets coated with Surelease did not change after
curing. However, Sadeghi [9] showed that diclofenac sodium
was released slightly faster than metoclopramide hydrochlo-
ride at equivalent coating loads; changes in the release rates
after curing were occurred for both metoclopramide hydro-
chloride and diclofenac sodium. In our research work, we
illustrate the mechanism of release for different drug coated
with Surelease thoroughly, which is different from the
reference [9]. It was reported that the slower release of
metoclopramide hydrochloride may be due to the formation
of a poorly soluble complex of the drug and the ammonium
oleate with large molecular size. This interaction may also
account for the differences in release characteristics of the
drugs after curing. But in our research, the complex of the
cationic drug and the ammonia could not decrease the drug
release, and could be destroyed easily after curing. The
coating film could be destroyed by the evaporated ammonia,
at the same time, the drug returned cationic form, so the
release was increased. And after curing, the film could be
destroy by the evaporated ammonia, thus, porous structure
would be formed, at the same time, the drug returned cationic
form, so the release was increased.
Moreover the succinic acid [10] and any other new concept
[11] can deserve the drug release of Surelease. The drug
release from Surelease coated pellets with high succinic acid
to drug ratios and different coating levels can obtain an ever
more constant rate and release rates. Some new concept
adapting the copolymer to aqueous ethylcellulose dispersion
also can be used to provide stable drugs release.
In general, there is no need to cure after coating by Sure-
lease. But the drug release would be increased when curing
after coated by Surelease. And, this occurs only in the
cationic drug. The major objectives of the study described in
this paper are to: (1) investigate whether there are significant
changes in the release rates after curing of propafenone hy-
drochloride (PPF, cationic drug) pellets coated with Sure-
lease; and (2) examine the factors that may explain these
changes. By comparing the influence of curing on the release
of metformin (MET, cationic drug), naproxen sodium (NPS,
anionic drug), and carbamazepine (CBZ, nonionic drug) pelletscoated with Surelease, the interaction of the cationic drug
with ammonia in Surelease is suggested to be the reason for
the changes in drug release.2. Materials and methods
2.1. Materials
The following materials were used in this research: prop-
afenone hydrochloride (Panya Chemical Co. Ltd, Shanghai
China; PPF), metformin (Shandong Keyuan Pharmaceutical
Co. Ltd, Jinan China; MET), carbamazepine (Hezhong Chemi-
cal Co. Ltd, Wuhan China; CBZ), naproxen sodium (Ruiteng
Chemical Co. Ltd, Shanghai China; NPS), microcrystalline
cellulose (Avicel PH101; FMC Ltd. Cork, Ireland), lactose (Bei-
jing Fengli Jinqiu Commerce and Trade Co. Ltd, Beijing China),
hydroxypropyl methylcellulose (HPMC, Methocel E5, Color-
con; Orpington UK), ethylcellulose aqueous dispersion (Sure-
lease E-7-7050, Colorcon, Darford, Kent, UK), polyvinyl
pyrrolidone K30, and sodium chloride (Bodi Pharmaceutical
Co. Ltd, Tianjin China).
2.2. Preparation of drug-loaded pellets
The different drug-loaded pellets are listed in Table 1. Drugs
and excipients were mixed by passing them through an 80-
mesh sieve three times. Binder solution was added until a
wet mass was formed and, then, the wet mass was extruded
using a Granulator (JBZ-300, Yilia Research Institute, Liaoning,
China) with a 1.0mmscreen at a rate of 58 rmp on a laboratory
scale (100 g). After that, the extrudedmaterial was transferred
to a spheronizer (JBZ-300, Yilia Research Institute, Liaoning,
China). The final pellets were obtained following spheroniza-
tion at a speed of 1000 rpm for 5 min. Finally, the pellets were
dried at 40 C for 12 h and then passed through a 16e24-mesh
sieve.
2.3. Seal-coating of pellets with HPMC E5
HPMC E5 (2%, w/w) solution was prepared. A 20 g sample of
drug-loaded pellets was transferred to the fluidized-bedded
coater (Yilia Research Institute, Liaoning, China) and the
coating levels were 2%, 4%, 6% by weight gain and then the
pellets were stored overnight. The coating process conditions
are listed in Table 2.
Table 2 e Coating conditions.
Conditions Seal-coating Polymer-coating
Inlet air temperature (C) 30e35 35e40
Spray rate (ml/min) 0.7e0.9 0.7e0.9
Atomizing air pressure (MPa) 38.0 36.0
Spray pressure (MPa) 0.5e0.7 0.5e0.7
Fig. 1 e Release of propafenone hydrochloride with
different coating levels of Surelease (n [ 6).
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Sureleasewas diluted to 15% and a 20 g batch of pellets, with
or without seal-coating, was coated with the diluted Sure-
lease under the conditions given in Table 2. After coating, the
pellets were further fluidized for 30 min to ensure that a film
was formed.
2.5. Curing of the final pellets
Each batch of final pellets was cured at 40 C or 60 C for 12 h.
2.6. Dissolution study
The behavior of the pellets was evaluated by in vitro dissolu-
tion tests (USP 31 dissolution apparatus 1). at a temperature of
37 0.5 C. After this, an aliquot of the fluid was withdrawn at
1, 2, 4, 6, 8, 10, 12 h. The samples were analyzed by UV-
spectrophotometry (RuiLi Analytical Apparatus Co. Ltd, Bei-
jing China). The mean cumulative release of the drugs was
investigated.
2.7. Assay of drug content
Weigh and fine powder not fewer than 20 times dose of pel-
lets. Transfer an accurately weighed portion of the powder,
equivalent to about 20 mg PPF to a 100 ml flask, diluted with
alcohol and sonicated until the drug dissolved completely.
Aliquots of the solution were filtered and the PPF contents
were measured at 248 nm. MET, NPS and CBZ contents were
also measured at 233 nm, 330 nm, and 285 nm, respectively.
2.8. Permeation of ammonia from the seal-coating
A solution of HPMC E5 5% (w/w) was uniformly spread onto a
glass plate and dried at 40 C for 12 h. Then, it was striped from
the glass plate.
The seal film was placed over a watch-glass filled with
ammonia. The pH of the test paper was used to determine
whether ammonia could permeate the seal film.
2.9. Stability test after storage under ammonia-
saturated conditions
PPF pellets cores and pellets coated with 10% Surelease over
a seal-coating of HPMC E5 and the pellets themselves were
both stored in a desiccator under ammonia saturation for 12 h
at room temperature. The PPF release from these two kinds of
pellets was measured and compared with pellets coated with
10% Surelease over a 6% seal-coating of HPMC E5without any
ammonia treatment.2.10. Scanning electron microscopy (SEM)
Dissolution tests of the PPF pellets (coated with 10% Sure-
lease), uncured and cured, at 40 C for 12 h were carried out
for 2 h.
The surfaces of the four kinds of pellets (uncured and
cured; before and after dissolution) were sputter-coated with
gold-palladium and examined by scanning electron micro-
scopy (Hitachi S-3400N Japan).3. Results and discussions
3.1. The influence of curing on PPF pellets coated with
Surelease
Usually, the release rate decreases as the coating level in-
creases. The release profiles for PPF pellets coated with Sure-
lease are shown in Fig. 1 (All the Figures were dealt with
Excel). However, in Fig. 2 the release rate of the cured pellets
increasedmarkedly and the release rate of the pellets cured at
60 C was much faster than those uncured. Their surface was
changed by curing as show in Fig. 3. Usually the curing can
result in further coalescence of the polymer particles and a
reduction in drug release. According to the mechanism of the
film formation of Surelease, the theoretical coating temper-
ature is 34e38 C. During coating, the film formed, and curing
is not necessary. Curing can contribute to the film formation
and reduce the release rate. However, in our study, for PPF, the
opposite release result was obtained after curing. The release
of PPF from the cured pellets coated with Surelease was
significantly faster than that of the uncured ones.
3.2. The influence of curing on PPF pellets coated with
Surelease and seal-coating layer
Migration of the active drug through the coating material
could lead to a porous structure, resulting in a change in the
release rate. So such an interaction may affect the drug
release. To avoid this migration, in our study, different levels
of HPMC were applied as a seal-coating. The release results of
the pellets coated with different levels of seal-coating and
polymer-coat are shown in Fig. 4. As the levels of seal-coating
Fig. 2 e Influence of curing on the release of PPF pellets coated with Surelease with weight gain of 10% (A) and 12% (B).
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the dissolution results suggested that the seal-coating was
unable to prevent the change in drug release after curing, the
changes were not so marked as the load of seal-coating
increased. However, under the different condition of curing
(the temperature of curing was 40 C and 60 C), the release of
the pellets coated with seal-coating was also markedly
increased, as shown in Fig. 5. So, the seal-coating could not
prevent the change in release of propafenone hydrochloride
pellets coated with Surelease after curing.
3.3. Permeation of ammonia from the seal-coating
After ruling out the possibility of themigration of the drug into
thepolymer-coating, thepreparationprocessofSureleasewas
investigated. Surelease is a kind of aqueous ethylcelluloseFig. 3 e SEM photographs of PPF pellets (coated with 10% Surele
and cured at 40 C for 12 h. (C: Magnification: 45; D: Magnificatidispersion,whichwaspreparedby thephasetransitionmethod
involving the melting of ethylcellulose and plasticizer (oleic
acid)byheating.During themeltingprocess,aqueousammonia
was added under high pressure. The aqueous suspension sys-
tem was formed by phase transition. During the preparation,
the plasticizer diffused into the polymer particles uniformly to
increase the plasticity of the suspension system. After the
phase transition, the plasticizer combined with ammonia can
diffuse in the polymer in order to keep the polymer stable. So,
there is no need to add the plasticizer while coating.
In order to determine the reason for the change in release,
we examined the interaction between the drug and ammo-
nium oleate in Surelease. According to themechanism of the
film formation, during the coating process ammonia evapo-
rates, leaving behind oleic acid rather than ammoniumoleate.
The oleic acid played the role of plasticizer, while thease) uncured (A: Magnification: 45; B: Magnification: 1000)
on: 1000).
Fig. 4 e Influence of curing on drug release from different levels of seal-coating PPF pellets coated with Surelease. (A)
Polymer-coat level was 10% and seal-coating level was 2%; (B) Polymer-coat level was 12% and seal-coating level was 2%; (C)
Polymer-coat level was 10% and seal-coating level was 4%; (D) Polymer-coat level was 12% and seat-coating was 4%; (E)
Polymer-coat level was 10% and seat-coating was 6%; (F) Polymer-coat level was 12% and seat-coating level was 6%.
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mer particles. As the resistance decreased, polymer particles
became closely packed and coalescence took place with the
help of the plasticizer. During coating, if the drying was
insufficient, the cationic drugs under moist conditions could
become ionize cations, which can interact with ammonia. As
shown in Fig. 3, the film of the uncured pellets coalesced
completely. However, after curing at 40 C, some pins
appeared on the surface of the pellets, caused by the evapo-
rated ammonia (Fig. 3). The difference between the cured and
uncured pellets was clear after the dissolution test. Also, after
the dissolution test, the film of the cured pellets split as shown
in Fig. 6.From the ammonia permeation test, the color of the allo-
chroic pH test paper over the seal film changed to blue, which
proved that ammonia was able to permeate the seal-coating
during coating.
3.4. Interaction between ammonia and cationic drug
According to the theory of Lewis, all substances which can
receive duplets are acids while all those which can provide
duplets are alkalis. Therefore, the essence of the acidebase
reaction can be summarized as the formation of a coordinate
bond and production of a coordination compound. From the
definition, the cationic drug can be taken as an acid and the
Fig. 5 e Influence of different curing times at 60 C on drug
release of PPF pellets coated with 10% Surelease over 6%
seal-coating.
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can be summarized as follows:
Anþ þ n½: NH35

AðNH3Þn
nþ
This kind of coordination compound can be formed
when the ammonia evaporates during the process of
coating of the cationic drug pellets with Surelease. At the
same time, the polymer film is also formed as the ammonia
evaporates, as shown by Fig. 3. The release of uncured
pellets shows that the sustained characteristics of the film
were very marked and the release decreased as the coatingFig. 6 e SEM photographs of PPF pellets (coated with 10% Surele
and cured at 40 C for 12 h (C) Magnification: 45 (D) Magnificatiolevel increased. However, after being cured, the release of
the drug changed significantly. During the curing process,
the ammonia of the coordination compound would be
evaporated. For this reason, the film might be destroyed by
the detached ammonia, thus, the drug release could in-
crease. Each coordination compound has a formation con-
stant (K), which is affected by a number of factors such as
heating and oxidoreduction.
K ¼ C½AðNH3Þnnþ=
h
CAnþ$C
n
½:NH3 
i
During coating, there is a lot of ammonia in Surelease, so
the balance of the reaction would move to the right of equa-
tion, much poorly coordination compound were formed, that
was, K was increased and the drug complex was decreased/
increased. When cured after coating, ammonia moved to left,
the coordination compound would decompose, the drug
existed in the form of cationic, and the evaporated ammonia
lead to porous structure on the surface, therefore, the drug
release was increased.3.5. Stability test after storage under ammonia-
saturated conditions
To confirm this interaction, the storage stability under
ammonia saturation was investigated. From Fig. 7,
compared with the release of the three kinds of pellets, the
release of the pellets treated with ammonia before coating
was faster than that of the untreated pellets. The reason for
this could be that during storage under ammonia satura-
tion, ammonia could combine with the cationic drug and bease) uncured (A) Magnification: 45 (B) Magnification: 1000
n: 1000 after dissolution for 2 h.
Fig. 7 e Influence of storage stability under ammonia-
saturated conditions on drug release of PPF pellets coated
with 10% Surelease over 6% seal-coating.
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of the polymer film. However, the release of pellets treated
with ammonia after coating became slower, which could be
due to the face that the ammonia outside polymer-coat
(HPMC) prevented the ammonia to deliver which was in-
side the polymer-coat. According to the equation, the
ammonia which inside the polymer-coat was combination
with the cationic drug to become poorly soluble complex
[A(NH3)n]
nþ, therefore, the drug could not release from theFig. 8 e Influence of 12 h curing at 40 C, 60Con the drug relea
weight gain Surelease.pellets. So, the film could coalesce without the ammonia
inside the polymer-coat. Therefore, the reason for the
changed release of propafenone hydrochloride pellets after
curing is due to the combination between the cationic drug
and the ammonia of Surelease during coating.
3.6. The influence of curing on another three kinds of
drug pellets coated with Surelease
In order to test the validity of this explanation, an investi-
gation was performed to examine the influence of curing on
the release of another three kinds of drug including MET (a
water-soluble cationic drug), NPS (anionic drug), and CBZ
(nonionic drug) from pellets coated with Surelease. The
results are shown in Fig. 8. The release rate of NPS and CBZ
did not change after curing, which suggested that the film
coalescence had taken place during coating. However, the
release rate of MET from the pellets coated with Surelease
showed a marked increase after curing. Comparison of the
results proved that only the cationic drug could cause a
change in the release of pellets coated with Surelease after
curing. So, the reason for the rate change is the interaction
of ammonia and the cationic drug.
3.7. The influence of coating conditions
The coating conditions of Surelease are very important in our
study. Possible reasons for this could be: firstly, the ammoniase of MET (A), NPS (B) and CBZ (C) pellets coated with 50%
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sion among the polymer particles. Secondly, the optimized
process provides sufficient drying, which can reduce the
combination of the drug with evaporated ammonia during
coating. Thirdly, the proper temperature during coating con-
tributes to the polymer film coalescence without curing. The
minimum film forming temperature of Surelease (MFT) is
about 23 C and the coating temperature is around 35e40 C or
higher. And spray rate is 0.7e0.9 (ml/min) with atomizing air
pressure 36.0 (MPa), with spray pressure 0.5e0.7 (MPa) or
higher. The higher coating temperature and spray pressure
can evaporate the ammonia during coating. Under optimized
processing conditions, the film could be formed during
coating and curing is not needed. The coating process needs to
be optimized when Surelease is chosen as the coating
material.4. Conclusions
Different from the anionic and nonionic drug, the cationic
drug could cause a change in the release of pellets coated with
Surelease after curing. The change of release rate after curing
is related to the combination between cationic drug and
ammonia in Surelease. And the combined ammonia can be
decomposed easily during curing. In addition, no migration
occurred during storage. Furthermore, the seal-coating could
not prevent the change of drug release of pellets coated with
Surelease after curing. The coating process needs to be
optimized when Surelease is chosen as the coating material
to obtain sufficient drying, which can reduce the combination
of the drug with evaporated ammonia during coating without
curing.r e f e r e n c e s
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